Company Pays to Resolve Claims of Controlled Substance Thefts

Company Pays to Resolve Claims of Controlled Substance Thefts

Company Pays to Resolve Claims of Controlled Substance Thefts

New York retail pharmacy employee who stole oxycodone was previously terminated for stealing Vicodin, then rehired.

RGIS LLC (RGIS) and its affiliated company, Retail Services WIS Corporation (WIS), agreed to pay $158,760 to resolve allegations that they caused violations of the Controlled Substances Act. RGIS and WIS employees were implicated in the theft of controlled substances from pharmacies in upstate New York and throughout the United States. As part of the settlement, RGIS and WIS are changing their policies to require more thorough vetting of employees assigned to inventory pharmacies nationwide.

RGIS and WIS provide inventory services to client-retail stores throughout the United States, including retail pharmacies. According to RGIS and WIS policies, only handpicked, high-caliber, well-respected employees are assigned to pharmacy inventory teams and they are required to undergo a drug test and criminal background check. RGIS and WIS maintain a “zero tolerance policy” for theft.

Despite these policies, RGIS and WIS employees were implicated in stealing controlled substances from several pharmacies. For example, in July 2017, an RGIS employee stole Vicodin pills while inventorying a retail pharmacy in Schenectady, New York. RGIS terminated the employee but later rehired him. In 2020, that same employee was implicated in stealing narcotics from three pharmacies in Fort Edward, Saratoga, and Glens Falls, New York. RGIS employees were also implicated in stealing narcotics from pharmacies in Kentucky, North Carolina, and Louisiana. In addition, WIS employees were implicated in stealing narcotics from pharmacies in Dallas, Duncanville, and Little Elm, Texas.

RGIS and WIS agreed to implement additional procedures to ensure the proper vetting of employees assigned to inventory pharmacies, and to make the results of the vetting available to their pharmacy-clients. The pharmacy-clients, as DEA registrants, are ultimately responsible for supervising all personnel on the premises and preventing the diversion of controlled substances.

Approximate date(s) of the diversion: 2017-07-01
Where the Diversion Occurred: Unknown Facility Saratoga, NY Type of Healthcare Facility: Hospital
Has the incident been reported? e.g. to local law enforcement, county board of health, state licensure board, and/or federal DEA or FDA authorities? Yes To whom has the incident been reported? Drug Enforcement Administration (DEA)
Publicly available news reports about the incident: